
Amphenol is Tuesday's IBD Stock Of The Day. Shares of the AI data-center tied play are forming a cup base after a second-quarter dive.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

Amphenol is Tuesday's IBD Stock Of The Day. Shares of the AI data-center tied play are forming a cup base after a second-quarter dive.
Record orders of $10.7 billion and 30% organic sales growth driven by AI demand.
NuScale's Q2 revenues plunged 98.8% as RoPower work wound down, while supplier progress and liquidity supported commercialization plans.
Amphenol stock has delivered very strong gains over the past few years, yet its latest valuation checks suggest the shares now lean expensive rather than clearly mispriced. Over 5 years, Amphenol has returned 386.9% to shareholders, which sets a high bar for any further upside to be justified by fundamentals. Expectations around Amphenol's ability to keep growing its revenue and cash flows can support the current share price, while any disappointment in profitability or capital returns may...
Q's Q2 earnings jump 53% as AI-driven demand lifts sales 22%, fueling segment growth and a higher 2026 outlook.
ENTG beats Q2 estimates as AI-linked chip investment lifts sales, margins and cash flow, while stronger bookings improve visibility into 2027.
QLYS tops Q2'26 estimates as channel revenues jump 22%, margins widen, and management raises its 2026 revenue and earnings outlook.
AME's Q2 earnings rise 17%, and revenues climb 15%, as stronger EIG and EMG sales support a higher 2026 outlook.
Ichor's Q2 earnings beat estimates as margin gains offset a revenue miss, while strong demand fuels upbeat 2026 growth and Q3 guidance.
VRT stock surges after strong Q2 2026 results as AI-driven data center demand, manufacturing expansion and upbeat guidance support continued growth.
WESCO tops Q2 earnings and revenue estimates as data center sales surge, backlog hits a record, and management raises its 2026 outlook.
Cohu's Q2 earnings and revenues beat estimates as AI compute demand, higher tester and recurring sales and a favorable mix lift results.
CHKP tops Q2 earnings estimates as subscription revenues rise and AI security demand expands, even as product sales and cash flow face pressure.
In late July 2026, Amphenol Corporation reported second-quarter 2026 results showing record sales of US$8.76 billion and net income of US$1.77 billion, alongside higher earnings per share versus the prior year. The company also issued upbeat third-quarter guidance, projecting US$9.30 billion to US$9.40 billion in sales, underpinned by strong AI-related IT datacom demand and contributions from recent acquisitions, including CommScope. We’ll now examine how this AI-driven demand surge and...
UMC beats Q2 estimates as revenues rise 8.4%, margins expand and record 22-nanometer sales strengthen results.
APH delivers record Q2 results as AI infrastructure demand, acquisitions and strong orders fuel growth across connectivity markets.
Amphenol (NYSE:APH) reported record second-quarter 2026 sales of $8.8 billion, up 55% year over year in U.S. dollars and 30% organically, as demand for artificial-intelligence infrastructure and broad strength across most end markets lifted results above the company’s guidance range. Adjusted dilut
Amphenol Corp (APH) posts record revenue of $8.8 billion and adjusted EPS of $1.35, driven by a 63% organic surge in IT datacom sales and a strong book-to-bill ratio of 1.23:1.
APH's Q2 earnings and revenues surge on strong IT datacom demand, broad organic growth and acquisitions, while record orders fuel upbeat Q3 guidance.
The headline numbers for Amphenol (APH) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Amphenol (APH) delivered earnings and revenue surprises of +13.45% and +5.51%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
GDDY approaches Q2 earnings with AI product momentum, platform enhancements, and revenue growth expectations amid competitive and macroeconomic headwinds.
ASX is set to report Q2 2026 results on July 30, with AI packaging demand, stronger EMS momentum and improving margins in focus.
Electrical connector manufacturer Amphenol (NYSE:APH) will be announcing earnings results this Wednesday before market open. Here’s what to expect.
PBI gears up to report Q2 2026 earnings on July 29, with SendTech momentum, Presort strength and cost discipline in focus.
CTSH's Q2 results are likely to benefit from strong bookings, AI momentum and acquisition support, but macro uncertainty and weak discretionary demand remain key risks.
UIS gears up to report Q2 earnings on July 29, with stronger signings in focus as AI demand, a growing backlog and automation support performance.
Tyler Technologies heads into Q2 earnings with cloud growth, SaaS migration and AI adoption in focus as investors watch whether higher R&D spending pressures margins.
Allegro MicroSystems' Q1 results are likely to reflect rising demand in automotive and industrial markets, but can product gains outweigh macro and pricing pressures?
GRMN heads into Q2 earnings with expectations for revenue growth as demand for fitness wearables and aviation products offsets Auto OEM weakness.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.